Studies on the interaction of warfarin and clofibrate in man.
D000244:Adenosine Diphosphate / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000328:Adult; D001777:Blood Coagulation / Q000187:drug effects*; D001792:Blood Platelets / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D002452:Cell Count; D002994:Clofibrate / Q000378:metabolism / Q000494:pharmacology*; D004347:Drug Interactions; D005164:Factor IX / Q000032:analysis; D005167:Factor VII / Q000032:analysis; D005170:Factor X / Q000032:analysis; D006474:Hemorrhagic Disorders / Q000139:chemically induced; D006801:Humans; D007020:Hypoprothrombinemias / Q000139:chemically induced; D008297:Male; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism; D010973:Platelet Adhesiveness / Q000187:drug effects; D011517:Prothrombin Time; D013997:Time Factors; D014859:Warfarin / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*
D014859:Warfarin; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D005167:Factor VII; D005164:Factor IX; D005170:Factor X; D010744:Phosphoric Monoester Hydrolases; D002994:Clofibrate